Bristol-Myers Loses Canadian Court Battle Over Taxol Alternative

Law360, New York (May 20, 2005, 12:00 AM EDT) -- A tiny Canadian drug maker has defeated U.S. drug giant Bristol-Myers Squibb Co. in a five-year patent battle over the right to sell an inexpensive cancer treatment that would compete with the blockbuster chemotherapy treatment Taxol.

As a result of the decision by the Supreme Court of Canada, Biolyse Pharma Corp. will have the right to market a drug that sells for one-third of the listed price for Bristol-Myer's competing drug Taxol.

In a 6-3 decision, the Supreme Court found that although Bristol-Myers had patent protection...
To view the full article, register now.